OPEN END TURBO OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Börse Stuttgart 15:45:21 2024-06-04 EDT | ||
| 10.38 EUR | -3.62% |
|
| Current month | -7.57% | ||
| 1 month | -13.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 10.38 | -3.62% |
| 24-06-03 | 10.77 | -4.10% |
| 24-05-31 | 11.23 | -4.83% |
| 24-05-30 | 11.8 | -3.20% |
| 24-05-29 | 12.19 | +3.31% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 03:45 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JA98P1 |
| ISIN | DE000JA98P13 |
| Date issued | 2022-06-24 |
| Strike | 346.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 13.46 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.18 € |
|---|---|
| Lowest since issue | 3.21 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
234.1
USD
Average target price
284.8
USD
Spread / Average Target
+21.63%
- Stock Market
- Certificates
- Certificat
